Additional file 1: of Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials

Abstract

Shows the reasons for exclusion of retrieved articles during full text screening. (DOCX 31 kb

    Similar works

    Full text

    thumbnail-image

    Available Versions